Valuation: Haemonetics Corporation

Market Cap 340.16Cr 298.95Cr 275.27Cr 256.16Cr 483.51Cr 32TCr 493.54Cr 3.31TCr 1.28TCr 16TCr 1.28TCr 1.25TCr 55TCr P/E 2027 *
19x
P/E 2028 * 16.8x
Enterprise Value 407.41Cr 358.05Cr 329.69Cr 306.8Cr 579.09Cr 39TCr 591.11Cr 3.96TCr 1.54TCr 19TCr 1.53TCr 1.5TCr 66TCr EV / Sales 2027 *
2.91x
EV / Sales 2028 * 2.57x
Free-Float
98.75%
Yield 2027 *
2.67%
Yield 2028 * -
1 day-0.20%
1 week+2.84%
Current month-0.20%
1 month+10.38%
3 months+32.81%
6 months-6.61%
Current year-6.61%
1 week 72.04
Extreme 72.04
79.82
1 month 65.06
Extreme 65.06
81.99
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.08
Extreme 29.08
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
05/06Tax

VP, Chief Accounting Officer

-259 0.0006%
05/06Tax

Head of Human Resources

-313 0.0007%
15/05Tax

Chief Financial Officer

-31,817 0.0685%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%+2.84%+0.32%-12.09% 340.84Cr
+1.59%+1.82%-32.23%-15.45% 16TCr
+1.24%-1.77%-9.14%-10.10% 10TCr
+1.92%+2.60%-3.81%+49.88% 5.51TCr
-0.17%-2.19%+51.01%+51.71% 5.34TCr
+1.04%+6.24%-11.23%-42.09% 4.17TCr
+5.81%+18.22% - - 3.34TCr
+2.24%-0.09%-21.11%-46.42% 2.6TCr
+1.67%+8.51%+66.82%-4.57% 2.54TCr
+0.82%+4.47%-11.62%-5.64% 2.05TCr
Average +1.53%+3.07%+3.22%-3.86% 5.17TCr
Weighted average by Cap. +1.40%+1.39%-6.32%-2.44%

Financials

2027 *2028 *
Net sales 140.04Cr 123.08Cr 113.33Cr 105.46Cr 199.06Cr 13TCr 203.19Cr 1.36TCr 527.73Cr 6.54TCr 525.87Cr 514.3Cr 23TCr 147.42Cr 129.56Cr 119.3Cr 111.02Cr 209.54Cr 14TCr 213.89Cr 1.43TCr 555.52Cr 6.88TCr 553.56Cr 541.38Cr 24TCr
Net income 17Cr 15Cr 14Cr 13Cr 25Cr 1.65TCr 25Cr 168.45Cr 65Cr 808.49Cr 65Cr 64Cr 2.81TCr 20Cr 18Cr 16Cr 15Cr 29Cr 1.93TCr 29Cr 197.49Cr 77Cr 947.87Cr 76Cr 75Cr 3.3TCr
Net Debt 67Cr 59Cr 54Cr 51Cr 96Cr 6.4TCr 98Cr 654.03Cr 253.4Cr 3.14TCr 252.51Cr 246.95Cr 11TCr 38Cr 34Cr 31Cr 29Cr 55Cr 3.66TCr 56Cr 374.26Cr 145.01Cr 1.8TCr 144.49Cr 141.32Cr 6.25TCr
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
01/26/01 $74.85 -0.20% 6,36,815
30/26/30 $75.00 -0.16% 5,62,613
29/26/29 $75.12 -2.81% 6,12,908
26/26/26 $77.29 -0.43% 16,08,297
25/26/25 $77.62 +6.52% 7,46,058
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
75.00USD
Average target price
85.20USD
Spread / Average Target
+13.60%

Quarterly revenue - Rate of surprise